Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50

United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$13.12M

$0.00 on a plan · $13.12M straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$13.12M

$0.00 against sales at will